Vitaspring Biomedical Co. Ltd.
VSBC· OTC
VSBCVitaspring Biomedical Co. Ltd.
Filed Mar 12, 2026 · 10-K · 771 days after period end · 0001640334-26-000426
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | $2.66K |
| Net Income | -$225.40K | -$4.16M | $17.27K | -$2.35K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR
ended Jan 31, 2024 · filed Mar 12, 2026 · 771 d after period end
